Monoclonal Antibody Treatment

What is it used for?
Monoclonal antibody infusions are used under Emergency Use Authorization and are authorized for the treatment of mild to moderate confirmed COVID-19 in outpatients 18 years and older whose symptoms onset occurred within the past 10 days and are at high risk of progression to severe COVID-19 and/or hospitalization.

What is it and what does it do?
A patient will receive either Casirivimab &  Imdevimab (REGEN-COV) or Bamlanivimab & Etesevimab based on availability. Each combination consists of monoclonal antibodies that are administered together. Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful pathogens, such as viruses like SARS-CoV-2.

Do I qualify?
Sumner Regional is able to provide monoclonal antibody infusion therapy if you meet the following criteria:

• Tested positive for COVID-19 and
• Symptom onset occurred within the past 10 days and
• Have one of the following high-risk conditions:
  • Age > 65
  • Heart disease
  • COPD or a chronic respiratory (lung) disease
  • Immunosuppressive disease or if you are currently receiving immunosuppressive treatment
  • Chronic kidney disease
  • Diabetes
  • Significant Obesity (BMI > 25)
  • Sickle cell disease
  • Neurodevelopmental disorder
  • Medical-related technological dependence
  • Pregnancy

Patients that qualify may present to our Emergency Department to be evaluated for treatment with a Monoclonal Antibody Infusion.

For more information about Monoclonal Antibody Therapy and to see if you qualify, call 615.328.2300 (Mon- Fri, 8 am - 4 pm).

Therapy hours: 9 am – 7 pm, daily

What are some reasons I may not qualify?

• Hospitalized due to COVID-19
• Require oxygen therapy due to COVID-19 or increase in baseline oxygen flow rate due to COVID-19
• It has been greater than 10 days since COVID-19 symptoms started
• Weight less than 88 pounds